PMC:7152526 / 114-411 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"15","span":{"begin":52,"end":99},"obj":"Species"},{"id":"17","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"18","span":{"begin":32,"end":40},"obj":"Disease"},{"id":"19","span":{"begin":243,"end":259},"obj":"Disease"},{"id":"20","span":{"begin":286,"end":294},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"Tax:2697049"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:C000657245"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"MESH:C000657245"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D001102"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tract\nCoronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 tr"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":156,"end":162},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"tract\nCoronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 tr"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T5","span":{"begin":32,"end":40},"obj":"Disease"},{"id":"T6","span":{"begin":52,"end":99},"obj":"Disease"},{"id":"T7","span":{"begin":52,"end":85},"obj":"Disease"},{"id":"T8","span":{"begin":243,"end":259},"obj":"Disease"},{"id":"T9","span":{"begin":286,"end":294},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"tract\nCoronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 tr"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":108,"end":111},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T3","span":{"begin":156,"end":162},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T4","span":{"begin":163,"end":166},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"tract\nCoronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 tr"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":243,"end":259},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"tract\nCoronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 tr"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":6,"end":260},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tract\nCoronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 tr"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T3","span":{"begin":6,"end":17},"obj":"NCBITaxon:11118"},{"id":"T4","span":{"begin":32,"end":40},"obj":"SP_7"},{"id":"T5","span":{"begin":52,"end":64},"obj":"SP_7"},{"id":"T6","span":{"begin":65,"end":76},"obj":"SP_7;UBERON:0001004"},{"id":"T7","span":{"begin":77,"end":99},"obj":"SP_7"},{"id":"T8","span":{"begin":156,"end":162},"obj":"UBERON:0001969"},{"id":"T9","span":{"begin":243,"end":248},"obj":"NCBITaxon:10239"},{"id":"T10","span":{"begin":286,"end":294},"obj":"SP_7"},{"id":"T9965","span":{"begin":6,"end":17},"obj":"NCBITaxon:11118"},{"id":"T84612","span":{"begin":32,"end":40},"obj":"SP_7"},{"id":"T53837","span":{"begin":52,"end":64},"obj":"SP_7"},{"id":"T52665","span":{"begin":65,"end":76},"obj":"SP_7;UBERON:0001004"},{"id":"T91803","span":{"begin":77,"end":99},"obj":"SP_7"},{"id":"T71695","span":{"begin":156,"end":162},"obj":"UBERON:0001969"},{"id":"T89918","span":{"begin":243,"end":248},"obj":"NCBITaxon:10239"},{"id":"T68910","span":{"begin":286,"end":294},"obj":"SP_7"}],"text":"tract\nCoronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 tr"}